Trials / Completed
CompletedNCT02108457
[18F] Flourothymidine (FLT) PET/CT Imaging for Gynecologic Cancers
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (actual)
- Sponsor
- Abramson Cancer Center at Penn Medicine · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine the effect of specific bone marrow maps developed with18F-FLT PET/CT imaging on the ability to spare proliferating bone marrow using proton beam radiotherapy compared to IMRT. Participants will be 18 years of age or old with a history of gynecologic cancer. Subjects will undergo 3 FLT-PET scans (one before treatment, one during the course of RT, and one 2-5 weeks after initiation of RT). Scans will take place in the Department of Radiation Oncology.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | [18F]Fluorothymidine (FLT) PET/CT Imaging |
Timeline
- Start date
- 2014-02-01
- Primary completion
- 2016-12-21
- Completion
- 2016-12-21
- First posted
- 2014-04-09
- Last updated
- 2021-03-30
- Results posted
- 2019-11-08
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02108457. Inclusion in this directory is not an endorsement.